Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Hewitt

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Drug News & Perspectives|August 11, 2010
The kinetic isotope effect in the search for deuterated drugsLiming Shao, Michael C Hewitt
Journal of the American Chemical Society|November 7, 2002
Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesisMichael C Hewitt, Daniel A Snyder, Peter H Seeberger
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I)Liming Shao, Fengjiang Wang, Michael C Hewitt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2005
Derivatives of tramadol for increased duration of effectLiming Shao, Craig Abolin, Michael C Hewitt, et al.
Nature|August 16, 2002
Synthetic GPI as a candidate anti-toxic vaccine in a model of malariaLouis Schofield, Michael C Hewitt, Krystal Evans, et al.
ACS Chemical Neuroscience|November 30, 2018
CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesNathan O Fuller, Antonella Pirone, Berkley A Lynch, et al.
Pharmacology, Biochemistry, and Behavior|May 20, 2015
Pharmacological evaluation of a novel phosphodiesterase 10A inhibitor in models of antipsychotic activity and cognitionPhilip G Jones, Michael C Hewitt, John E Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2015
Evolution and synthesis of novel orally bioavailable inhibitors of PDE10ADouglas F Burdi, John E Campbell, Jun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitorLiming Shao, Jianguo Ma, Fengjiang Wang, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drug News & Perspectives|August 11, 2010
The kinetic isotope effect in the search for deuterated drugsLiming Shao, Michael C Hewitt
Journal of the American Chemical Society|November 7, 2002
Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesisMichael C Hewitt, Daniel A Snyder, Peter H Seeberger
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I)Liming Shao, Fengjiang Wang, Michael C Hewitt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2005
Derivatives of tramadol for increased duration of effectLiming Shao, Craig Abolin, Michael C Hewitt, et al.
Nature|August 16, 2002
Synthetic GPI as a candidate anti-toxic vaccine in a model of malariaLouis Schofield, Michael C Hewitt, Krystal Evans, et al.
ACS Chemical Neuroscience|November 30, 2018
CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesNathan O Fuller, Antonella Pirone, Berkley A Lynch, et al.
Pharmacology, Biochemistry, and Behavior|May 20, 2015
Pharmacological evaluation of a novel phosphodiesterase 10A inhibitor in models of antipsychotic activity and cognitionPhilip G Jones, Michael C Hewitt, John E Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2015
Evolution and synthesis of novel orally bioavailable inhibitors of PDE10ADouglas F Burdi, John E Campbell, Jun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitorLiming Shao, Jianguo Ma, Fengjiang Wang, et al.
Pageof 3